aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Becton Dickinson (BD) is a global medical technology company dedicated to advancing health by enhancing medical discovery, diagnostics, and care delivery. BD specializes in patient and healthcare worker safety and develops technologies for medical research and clinical laboratories. The company serves healthcare institutions and professionals worldwide.
BD has achieved significant milestones in medical technology innovation, contributing to improved healthcare outcomes globally. The company is known for its leadership in safety-engineered devices and diagnostic solutions, impacting millions of patients and healthcare workers.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Supplies
Tags
Healthtech
Model Types
Distribution, Hardware
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Government
When was Becton Dickinson founded?
Becton Dickinson was founded in 1897.
Where is Becton Dickinson’s headquarters located?
Becton Dickinson’s headquarters is located in Rutherford, NJ, US.
When was Becton Dickinson’s last funding round?
Becton Dickinson’s most recent funding round was for $540M (USD) in August 2023.
How many employees does Becton Dickinson have?
Becton Dickinson has 75000 employees as of Feb 6, 2024.
How much has Becton Dickinson raised to-date?
As of July 05, 2023, Becton Dickinson has raised a total of $579M (USD) since Aug 2, 2023.
Add Comparison
Total Raised to Date
$579M
USD
Last Update Aug 2, 2023
Last Deal Details
$540M
USD
Aug 2, 2023
Post Ipo Equity
Total Employees Over Time
75000
As of Feb 2024
Becton Dickinson Address
Rutherford,
New Jersey
07070
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts